EuroEyes International Eye Clinic Limited

德視佳國際眼科有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1846)

FORM OF PROXY FOR ANNUAL GENERAL MEETING

TO BE HELD ON 21 MAY 2021

I/We(Note 1)

of

being the registered holder(s) of

shares(Note 2) of US$0.01 each in the capital of EuroEyes International Eye

Clinic Limited (the "Company"), HEREBY APPOINT the chairman of the meeting or(Note 3)

of

as my/our proxy to attend, act and vote for me/us at the Annual General Meeting (or at any adjournment thereof) of the Company to be held at Pacific Room, 16/F, Tower 5, The Gateway, Harbour City, 15 Canton Road, Tsim Sha Tsui, Kowloon, Hong Kong on Friday, 21 May 2021 at 4:00 p.m. for the purpose of considering and, if thought fit, passing the ordinary resolutions set out in the notice convening the said meeting and at such meeting (or at any adjournment thereof) to vote for me/us and in my/our name(s) in respect of the resolutions as indicated below4.

ORDINARY RESOLUTIONS

For(Note 4)

Against(Note 4)

1.

To receive, consider and adopt the audited consolidated financial statements of the Company and its

subsidiaries, and the reports of the Directors and auditor of the Company for the year

ended

31 December 2020.

2.

To approve and declare a final dividend of HK$0.02988 per share for the year ended 31 December

2020.

3.

(i)

To re-elect Dr Ralf-Christian Lerche as an executive director.

(ii)

To re-elect Mr Marcus Huascar Bracklo as a non-executive director.

(iii)

To re-elect Mr Philip Duncan Wright as an independent non-executive director.

(iv) To re-elect Ms Katherine Rong Xin as an independent non-executive director.

(v) To authorize the board of directors to fix the respective directors' remuneration.

4.

To re-appoint PricewaterhouseCoopers as Auditor and to authorize the board of directors to fix the

Auditor's remuneration.

5.

To approve by an ordinary resolution, the granting of a general and unconditional mandate to the

Board to issue new shares of the Company.#

6.

To approve by an ordinary resolution, the granting of a general and unconditional mandate to the

Board to repurchase the Company's own shares.#

7.

To approve by an ordinary resolution, the inclusion of the aggregate nominal amount of shares

repurchased by the Company to the mandate granted under ordinary resolution no. 6.#

  • The full of text of the resolution is set out in the notice of the Annual General Meeting.

Date:

Signature:(Note 5)

Notes:

  1. Full name(s) and address(es) to be inserted in BLOCK CAPITALS.
  2. Please insert the number of shares registered in your name(s). If no number is inserted, this form of proxy will be deemed to relate to all the shares in the Company registered in your name(s). Where there are joint holders of any share, any one of such joint holder may vote, either personally or by proxy, in respect of such share as if he were solely entitled thereto provided that if more than one of such joint holders be present at the meeting personally or by proxy, that one of the said persons so present in person or by proxy whose name stands first in the register of members of the Company in respect of such share shall alone be entitled to vote in respect thereof.
  3. If any proxy other than the chairman is preferred, strike out "the chairman of the meeting" here and insert the name and address of the proxy desired in the space provided.
    ANY ALTERATION MADE TO THE FORM OF PROXY MUST BE INITIALLED BY THE PERSON WHO SIGNS IT.
  4. IMPORTANT: IF YOU WISH TO VOTE FOR A RESOLUTION, TICK ("") THE APPROPRIATE BOX MARKED "FOR". IF YOU WISH TO VOTE AGAINST THE RESOLUTION, TICK ("") THE BOX MARKED "AGAINST". Failure to complete any or all the boxes will entitle your proxy to cast his vote at his/her discretion. Your proxy will also be entitled to vote at his discretion on any resolution properly put to the meeting other than those referred to in the notice covering the meeting.
  5. This form of proxy must be signed by you or your attorney duly authorised in writing or, in the case of a corporation, must be either under its common seal or under the hand of an officer or attorney duly authorised.
  6. To be valid, this form of proxy, together with any power of attorney or other authority, if any, under which it is signed or a notarially certified copy or office copy thereof, must be deposited at the Company's share registrar in Hong Kong, Tricor Investor Services Limited, at Level 54, Hopewell Centre, 183 Queen's Road East, Hong Kong not less than 48 hours before the time appointed for holding the meeting.
  7. The proxy need not be a member of the Company but must attend the meeting in person to represent you.
  8. Completion and delivery of the form of proxy will not preclude you from attending and voting at the meeting if you so wish.

PERSONAL INFORMATION COLLECTION STATEMENT

Your supply of your and your proxy's (or proxies') name(s) and address(es) is on a voluntary basis for the purpose of processing your request for the appointment of a proxy (or proxies) and your voting instructions for the Annual General Meeting (the"Purposes"). We may transfer your and your proxy's (or proxies') name(s) and address(es) to our agent, contractor, or third party service provider who provides administrative, computer and other services to us for use in connection with the Purposes and to such parties who are authorised by law to request the information or are otherwise relevant for the Purposes and need to receive the information. Your and your proxy's (or proxies') name(s) and address(es) will be retained for such period as may be necessary to fulfil the Purposes. You/your proxy (or proxies) has/have the right to request access to and/or correction of the relevant personal data in accordance with the provisions of the Personal Data (Privacy) Ordinance (Chapter 486 of the Laws of Hong Kong), and any such request should be in writing by mail to:

Privacy Compliance Officer

Tricor Investor Services Limited

Level 54, Hopewell Centre, 183 Queen's Road East, Hong Kong

Attachments

  • Original document
  • Permalink

Disclaimer

Euroeyes International Eye Clinic Ltd. published this content on 20 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 April 2021 09:17:05 UTC.